Therapeutic anti-tumor effect of exogenous apoptin driven by human survivin gene promoter in a lentiviral construct

Archives of Medical Science

Volumn 9, Issue 3, 2013, Pages 562-568

  Ye, Feng ^a   Zhong, Bo ^b   Dan, Guorong ^a   Jiang, Fan ^a   Sai, Yan ^a   Zhao, Jiqing ^a   Sun, Huiqin ^a   Zou, Zhongmin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHWEST HOSPITAL   (China)

Author keywords

Apoptin; Gene therapy; Lentivirus; Survivin promoter; Tumor suppression

Indexed keywords

APOPTIN; LENTIVIRUS VECTOR; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SIZE; CELL ACTIVITY; CELL CYCLE G1 PHASE; CELL DEATH; CELL GROWTH; CELL POPULATION; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

EID: 84879822561     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2013.35423     Document Type: Article

References (30)

1. Danen-Van Oorschot AA, Fischer DF, Grimbergen JM, et al. Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci U S A 1997; 94: 5843-7. (Pubitemid 27241859)
2. Poon IK, Oro C, Dias MM, Zhang JP, Jans DA. A tumor cellspecific nuclear targeting signal within chicken anemia virus VP3/apoptin. J Virol 2005; 79: 1339-41. (Pubitemid 40053918)
3. Zhou S, Zhang M, Zhang J, Shen H, Tangsakar E, Wang J. Mechanisms of apoptin-induced cell death. Med Oncol 2012; 29: 2985-91.
4. Backendorf C, Visser AE, de Boer AG, et al. Apoptin: therapeutic potential of an early sensor of carcinogenic transformation. Annu Rev Pharmacol Toxicol 2008; 48: 143-69. (Pubitemid 351756360)
5. Noteborn MHM. Proteins selectively killing tumor cells. Eur J Pharmacol 2009; 625: 165-73.
6. Schoop RA, Kooistra K, Baatenburg De Jong RJ, Noteborn MH. Bcl-xL inhibits p53- but not apoptin-induced apo - ptosis in head and neck squamous cell carcinoma cell line. Int J Cancer 2004; 109: 38-42. (Pubitemid 38160659)
7. Pietersen AM, van der Eb MM, Rademaker HJ, et al. Specific tumor-cell killing with adenovirus vectors containing the apoptin gene. Gene Ther 1999; 6: 882-92. (Pubitemid 29243663)
8. Pan Y, Fang L, Fan H, et al. Antitumor effects of a re - combinant pseudotype baculovirus expressing apoptin in vitro and in vivo. Int J Cancer 2010; 126: 2741-51.
9. Mita AC, Mita MM, Nawrocki ST, Giles FJ. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 2008; 14: 5000-5.
10. Li X, Liu Y, Wen Z, et al. Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo. Mol Cancer 2010; 9: 10.
11. Van Houdt WJ, Haviv YS, Lu B, et al. The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma. J Neurosurg 2006; 104: 583-92.
12. Xiang J, Ouyang Y, Cui Y, et al. Silencing of Notch3 Using shRNA driven by survivin promoter inhibits growth and promotes apoptosis of human T-cell acute lymphoblastic leukemia cells. Clin Lymphoma Myeloma Leuk 2012; 12: 59-65.
13. Luo XR, Li JS, Niu Y, Miao L. Targeted killing effects of double CD and TK suicide genes controlled by survivin promoter on gastric cancer cell. Mol Biol Rep 2011; 38: 1201-7.
14. Huang R, Zhao Z, Ma X, Li S, Gong R, Kuang A. Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter. Cancer Gene Ther 2011; 18: 144-52.
15. Matrai J, Chuah MK, VandenDriessche T. Recent advances in lentiviral vector development and applications. Mol Ther 2010; 18: 477-90.
16. Liu GB, Cheng YX, Feng YK, et al. Adipose-derived stem cells promote peripheral nerve repair. Arch Med Sci 2011; 7: 592-6.
17. Hao L, Wang J, Zou Z, et al. Transplantation of BMSCs expressing hPDGF-A/hBD2 promotes wound healing in rats with combined radiation-wound injury. Gene Ther 2009; 16: 34-42.
18. Qin XF, An DS, Chen IS, Baltimore D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 2003; 100: 183-8. (Pubitemid 36078049)
19. Lu B, Makhija SK, Nettelbeck DM, et al. Evaluation of tumor-specific promoter activities in melanoma. Gene Ther 2005; 12: 330-8. (Pubitemid 40310135)
20. Peng DJ, Sun J, Wang YZ, et al. Inhibition of hepa - tocarcinoma by systemic delivery of Apoptin gene via the hepatic asialoglycoprotein receptor. Cancer Gene Ther 2007; 14: 66-73. (Pubitemid 44952235)
21. Los M, Panigrahi S, Rashedi I, et al. Apoptin, a tumorselective killer. Biochim Biophys Acta 2009; 1793: 1335-42.
22. Garg H, Salcedo R, Trinchieri G, Blumenthal R. Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax. Cancer Gene Ther 2010; 17: 155-63.
23. Zhu ZB, Makhija SK, Lu B, et al. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter. Cancer Gene Ther 2004; 11: 256-62. (Pubitemid 41184344)
24. Li F, Altieri DC. Transcriptional analysis of human survivin gene expression. Biochem J 1999; 344: 305-11. (Pubitemid 30011584)
25. Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580-4. (Pubitemid 28563719)
26. Xu R, Zhang P, Huang J, Ge S, Lu J, Qian G. Sp1 and Sp3 regulate basal transcription of the survivin gene. Biochem Biophys Res Commun 2007; 356: 286-92. (Pubitemid 46413162)
27. Sun H, Wang M, Hao L, Wang J, Su Y, Zou Z. Human betadefensins improve wound healing through a mechanism affecting multi-aspects of healing process. In: Advances in wound care. Vol. 2. Sen CK (ed.). Mary Ann Liebert, Inc., Danbury, USA, 2011; 149-54.
28. Konopka K, Spain C, Yen A, Overlid N, Gebremedhin S, Duzgunes N. Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells. Cell Mol Biol Lett 2009; 14: 70-89.
29. Fukuda S, Pelus LM. Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 2006; 5: 1087-98. (Pubitemid 43881300)
30. Kashani IR, Golipoor Z, Akbari M, et al. Schwann-like cell differentiation from rat bone marrow stem cells. Arch Med Sci 2011; 7: 45-52.